MIRA INFORM REPORT

 

 

Report Date :

17.01.2008

 

IDENTIFICATION DETAILS

 

Name :

M.P.I. PHARMACEUTICA GMBH

 

 

Registered Office :

Ballindamm 8 20095 Hamburg

 

 

Country :

Germany

 

 

Date of Incorporation :

19.09.1985

 

 

Legal Form :

Private Limited Company

 

 

Line of Business :

Manufacture of Pharmaceutical Specialities and Preparations

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

EUR 57.000,00.

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 


name and address of the company

 

M.P.I. Pharmaceutica GmbH

Ballindamm 8

20095 Hamburg

Post Box:  760905

Telephone: 040/3037240

Telefax:   040/30372420-21

Homepage:  www.mpi-pharma.com

E-Mail:    info@mpi-pharma.de

 

 

VAT no.

 

 DE118671386

 

 

SOLVENCY RATING

 

2,2

 

 

CONCLUSION

 

The maximum credit is EUR 57.000,00.

Business relations are permissible.

 

 

LEGAL FORM

 

 Private limited company

 

 

Date of foundation

 

 13.09.1985

 

 

Shareholders' agreement

 

13.09.1985

 

 

Registered on

 

26.08.1997

 

 

Commercial Register

 

Local court 20355 HAMBURG 36

under:               HRB 65217

 

 

Share capital

 

EUR            128.334,26

 

 

Shareholder

 

Franz Wilhelm Gerhardy

Giesestr. 9

22607 Hamburg

born 12.05.1941

Share:             EUR            128.334,26

 

 

Manager

 

Franz Wilhelm Gerhardy

Giesestr. 9

22607 Hamburg

having sole power of representation

born 12.05.1941

Occupation: Businessman

Marital status: married

 

 

Proxy

 

Christoph Frese

20095 Hamburg

born 03.03.1938

 

 

Further functions/participations of Franz Wilhelm Gerhardy

(Manager)

 

Manager:

IMEDIKA Chemie GmbH

Rehblöcken 38

22359 Hamburg

Legal form: Private limited company

Share capital:     EUR             25.000,00

Reg. Data:  20.12.2002

HRB 85890

20355 HAMBURG 36

 

 

BUSINESS HISTORY

 

07.09.1998           M.P.I. Pharmaceutica GmbH

Spohrstr. 2

22083 Hamburg

Private limited company

 

 

BUSINESS ACTIVITIES

 

24420

MANUFACTURE OF PHARMACEUTICAL SPECIALITIES AND PREPARATIONS

51461

WHOLESALE TRADE IN PHARMACEUTICAL GOODS

 

 

FINANCIAL INFORMATION

 

Solvency rating:      2,2

Payment experience:  within agreed terms

 

 

REAL ESTATE

 

Type of ownership:         Tenant

Address                        Ballindamm 8

20095 Hamburg

 

Land register documents were not available.

 

 

BANKERS

 

DEUTSCHE BANK, HAMBURG

Sort. code: 20070000, Account No: 6426605

BAYER HYPOVEREINSBANK EX VEREINS UND WESTBANK, HAMBURG

Sort. code: 20030000, Account No: 1160126

HAMBURGER SPARKASSE, HAMBURG

Sort. code: 20050550, Account No: 1280117357

 

 

FIGURES

 

Financial year:      01.01. - 31.12.

Turnover:            2006                EUR          3.345.000,00

Share capital:                            EUR             128.334,26

Total number of vehicles:                                       1

- Cars (owned):                                                   1

Employees:                                                           15

 

Approximate figures are given.


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NR

In view of the lack of information, we have no basis upon which to recommend credit dealings

No Rating

 

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions